Microvasculature and VEGF expression in cartilaginous tumors

被引:61
作者
Ayala, G
Liu, C
Nicosia, R
Horowitz, S
Lackman, R
机构
[1] Baylor Coll Med, Dept Pathol & Lab Med, Houston, TX 77040 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA
[3] Univ Washington, VA Puget Sound Healthcare Syst, Seattle, WA 98195 USA
[4] Univ Washington, Dept Pathol & Lab Med, Seattle, WA 98195 USA
[5] MCPHU, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA
[6] MCPHU, Sch Med, Dept Orthoped Surg, Philadelphia, PA USA
关键词
chondrosarcoma; angiogenesis; VEGF; immunoperoxidase;
D O I
10.1016/S0046-8177(00)80248-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We examined the microvasculature and VEGF expression in 26 cartilaginous lesions (CL) including 5 enchondromas, 9 grade 1 chondrosarcoma (CS), 6 grade 2 CS, 4 grade 3 CS, 1 mesenchymal, and 1 myxoid chondrosarcoma. The degree of neovascularization was measured by counting microvessels on H&E and factor VIII related antigen immunostained slides. Vessels were divided into pericartilage vessels (PCV) and intracartilage vessels (ICV). PVC comprised vessels around the lobules or invading the lobules but themselves surrounded by noncartilaginous stroma (ie, fibrous stroma); ICV consisted of those vessels present inside the tumoral nodules and in direct apposition with malignant cells or tumoral stroma. A direct correlation was seen between histological type and grade of CS and pericartilage vessels. In contrast, ICV were found only in higher-grade CS, No enchondromas and only 1 of 9 grade 1 CS had ICV. This patient had Oilier's disease. All but 2 of the grade 2 CS showed ICV (average, 20.5). The exceptions were predominantly grade 1 CS with focal grade 2 areas and extensive areas of necrosis. All but 1 grade 3 CS had ICV, the exception being a case of metastatic CS to the lung. Malignant chondrocytes of high-grade lesions stained strongly for vascular endothelial growth factor (VEGF), a potent angiogenic factor. The only high-grade tumors that did not express VEGF did not show ICV either. Enchondromas and grade 1 CS, most without ICV, did not express VEGF. In summary, PCV are present in all categories of tumoral cartilage and the number increases with histological grade; ICV are found in high-grade lesions, and the exceptions show extensive necrosis; VEGF expression by malignant chondrocytes is seen in high-grade lesions almost exclusively and among these in those lesions that showed intracartilage vessels. It is possible that PCV are involved in supporting tumor growth, whereas ICV might be involved in the acquisition of metastatic potential by cartilage tumors. VEGF expression is strongly associated with the presence of ICV. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:341 / 346
页数:6
相关论文
共 24 条
[1]   Vascular permeability factor vascular endothelial growth factor and vascular stroma formation in neoplasia: Insights from in situ hybridization studies [J].
Brown, LF ;
Guidi, AJ ;
Tognazzi, A ;
Dvorak, HF .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1998, 46 (05) :569-575
[2]   Transferrin promotes endothelial cell migration and invasion: Implication in cartilage neovascularization [J].
Carlevaro, MF ;
Albini, A ;
Ribatti, D ;
Gentili, C ;
Benelli, R ;
Cermelli, S ;
Cancedda, R ;
Cancedda, FD .
JOURNAL OF CELL BIOLOGY, 1997, 136 (06) :1375-1384
[3]   Thrombolysis for acute stroke [J].
Davis, SM ;
Donnan, GA .
JOURNAL OF CLINICAL NEUROSCIENCE, 1997, 4 (01) :1-2
[4]   VASCULARIZATION AND ENDOCHONDRAL BONE-DEVELOPMENT - CHANGES IN PLASMINOGEN-ACTIVATOR ACTIVITY [J].
DESIMONE, DP ;
REDDI, AH .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1992, 10 (03) :320-324
[5]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[6]  
FECHNER RF, 1992, ATLAS TUMOR PATHOL, P79
[7]   Intrinsic control of vascularization in developing cartilage rudiments [J].
Fenwick, SA ;
Gregg, PJ ;
Kumar, S ;
Smith, J ;
Rooney, P .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1997, 78 (03) :187-196
[8]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[9]  
Folkman J, 1992, Semin Cancer Biol, V3, P65
[10]   TUMOR ANGIOGENESIS [J].
FOLKMAN, J .
ADVANCES IN CANCER RESEARCH, 1985, 43 :175-203